Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%222019-nCoV%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%222019-nCoV%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%222019-nCoV%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (38)
1
Effectiveness of interactive web-based destigmatisation program in reducing stigma among COVID-19 survivors : Effectiveness of interactive web-based destigmatisation program in reducing stigma among COVID-19 survivors; randomised controlled trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Effectiveness of interactive web-based destigmatisation program in reducing stigma among COVID-19 survivors : Effectiveness of interactive web-based destigmatisation program in reducing stigma among COVID-19 survivors; randomised controlled trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Objective to evaluate the efficacy of Xuebijing injection in treating 2019 novel coronavirus (2019-nCoV) : a prospective multicenter cohort study. : Objective to evaluate the efficacy of Xuebijing injection in treating 2019 novel coronavirus (2019-nCoV) : a prospective multicenter cohort study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Objective to evaluate the efficacy of Xuebijing injection in treating 2019 novel coronavirus (2019-nCoV) : a prospective multicenter cohort study. : Objective to evaluate the efficacy of Xuebijing injection in treating 2019 novel coronavirus (2019-nCoV) : a prospective multicenter cohort study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) : A Virtual Phase 2 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of the Combination of Famotidine and Celecoxib as a Post-exposure Prophylaxis (PEP) for Newly-infected COVID-19 Patients
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation : Evaluation of the Artificial Intelligence/Machine Learning-Based Diagnostic Software as a Medical Device Using Forced Cough Vocalization Signal Data Signatures in the Diagnosis of COVID-19 Illness: A Prospective, Two-Arm Non-Inferiority Clinical Validation Trial of AudibleHealth Dx Software as a Medical Device (EUA-US)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
COVIPLA-R : Study on the use of Convalescent plasma therapy as a COVID-19 treatment - Study on the use of Convalescent plasma therapy as a COVID-19 treatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
COVIPLA-R : Study on the use of Convalescent plasma therapy as a COVID-19 treatment - Study on the use of Convalescent plasma therapy as a COVID-19 treatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia : A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of Novel Coronavirus (2019-nCoV) Pneumonia
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia : A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of Novel Coronavirus (2019-nCoV) Pneumonia
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
38
Aufsätze
38
E-Artikel
38
E-Ressourcen
Zeitschriftentitel
20
ClinicalTrials.gov
18
WHO International Clinical Trials Registry Plat...
Thema
38
610
22
Study Type: Interventional
13
Recruitment Status: Not yet recruiting
12
Study Type: Observational
11
Recruitment Status: Recruiting
10
Pneumonia
8
Recruitment Status: Completed
7
Coronavirus Infections
7
Medical Condition: 2019-nCoV
5
COVID-19
5
Phase: Phase 2
5
Phase: Phase 4
3
Communicable Diseases
3
Medical Condition: 2019-nCoV Pneumonia
3
Recruitment Status: Terminated
2
Infection
2
Infections
2
Medical Condition: 2019 - nCoV pneumonia
2
Medical Condition: 2019 novel coronavirus (2019...
2
Medical Condition: 2019-nCoV acute respiratory ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2023
8
2022
5
2021
21
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
36
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...